Who We Are

Walden Biosciences is a biotechnology company relentlessly focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease.

We are developing breakthrough medicines targeted directly to the kidney and will be successful through our comprehensive knowledge and understanding of novel kidney-specific biological pathways and our team’s track record in drug discovery.

We utilize our mechanistic understanding of kidney function in health and disease to provide patients with real treatment options, which target the kidney at the site of drug action.


A future where patients are unrestricted by kidney disease


To transform the treatment of kidney disease by reversing its progression, enabling and inspiring patients to resume their normal lives

Blaine McKee, Ph.D.
President and Chief Executive Officer
Alex Duncan, Ph.D.
Chief Scientific Officer
Our science is changing the treatment of kidney disease for patients